Revelation Biosciences, Inc., a clinical-stage life sciences company focused on the development of immunologic‑based therapies for the prevention and treatment of disease, and Petra Acquisition, Inc., today announced they have entered into a definitive merger agreement for a business combination that will result in Revelation becoming a publicly-traded company.
WeWork: An Intriguing Investment For A Post-COVID Workforce
Remote and hybrid work will be a permanent shift in the labor force. WeWork was surprisingly resilient in 2020 and managed to cut billions in excess costs.
SPACs and Covid spark M&A frenzy not seen since the dotcom boom
Deals worth $1.3tn were struck in the first quarter of 2021 in a year-to-date record driven by a number of mega deals and the surge in SPACs.
23andMe in Talks to Go Public Via Branson SPAC
Consumer DNA-testing company 23andMe Inc. is in talks to go public through a roughly $4 billion deal with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson, according to people familiar with the matter.